Meta-analysis: Tumour invasion-related genetic polymorphisms and gastric cancer susceptibility

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 5, 2008, Pages 565-573

  Gao, L ^a   Nieters, A ^a   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANGIOGENESIS; ARTICLE; ASIAN; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CAUCASIAN; CDH1 GENE; CELL ADHESION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMACH CANCER; TUMOR GENE;

BIOLOGICAL MARKERS; CADHERINS; FEMALE; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 48349148643     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03760.x     Document Type: Article

References (50)

1. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006 20 : 633 49.
2. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975 2 : 58 60.
3. Murakami K, Kodama M, Fujioka T. Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis. World J Gastroenterol 2006 12 : 2713 20.
4. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005 96 : 1 6.
5. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003 56 : 1 9.
6. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002 100 : 249 60.
7. Roberts-Thomson IC, Butler WJ. Polymorphism and gastric cancer. J Gastroenterol Hepatol 2005 20 : 793 4.
8. Correa P. New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J Surg Oncol 2005 90 : 134 8.
9. Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci 2006 97 : 1129 38.
10. Cochran WG. The combination of estimates from different experiments. Biometrics 1954 10 : 101 29.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003 327 : 557 60.
12. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994 50 : 1088 101.
13. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997 315 : 629 34.
14. Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002 21 : 8192 5.
15. Pharoah PD, Oliveira C, Machado JC, et al. CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. Int J Cancer 2002 101 : 196 7.
16. Wu MS, Huang SP, Chang YT, et al. Association of the -160 C - > a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002 94 : 1443 8.
17. Kuraoka K, Oue N, Yokozaki H, et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 2003 23 : 421 7.
18. Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003 18 : 501 4.
19. Lu Y, Xu YC, Shen J, et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005 11 : 56 60.
20. Medina-Franco H, Ramos-De la Medina A, Vizcaino G, Medina-Franco JL. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population. Ann Surg Oncol 2007 14 : 2246 9.
21. Yamada H, Shinmura K, Ikeda S, et al. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 2007 42 : 1479 85.
22. Zhang XF, Wang YM, Ge H, et al. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 2008 21 : 21 9.
23. Jenab M, McKay JD, Ferrari P, et al. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer 2008 44 : 774 80.
24. Matsumura S, Oue N, Kitadai Y, et al. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 2004 130 : 259 65.
25. Jin X, Kuang G, Wei LZ, et al. No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol 2005 11 : 2385 9.
26. Miao X, Yu C, Tan W, et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003 63 : 3987 90.
27. Kubben FJ, Sier CF, Meijer MJ, et al. Clinical impact of MMP and TIMP genetic polymorphisms in gastric cancer. Br J Cancer 2006 95 : 744 51.
28. Wu CY, Wu MS, Chen YJ, et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer 2007 43 : 799 808.
29. Zhang J, Jin X, Fang S, et al. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 2004 25 : 2519 24.
30. Zhang J, Jin X, Fang S, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005 26 : 1748 53.
31. Matsumura S, Oue N, Nakayama H, et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 2005 131 : 19 25.
32. Yang L, Gu HJ, Zhu HJ, et al. Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population. Eur J Surg Oncol 2008 34 : 636 41.
33. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A. Influences of chymase and angiotensin I-converting enzyme genetic polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006 15 : 1929 34.
34. Ebert MP, Lendeckel U, Westphal S, et al. The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 2005 14 : 2987 9.
35. Goto Y, Ando T, Nishio K, et al. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 2005 6 : 464 7.
36. Röcken C, Lendeckel U, Dierkes J, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005 11 : 2526 30.
37. Sugimoto M, Furuta T, Shirai N, et al. Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis 2007 28 : 2036 40.
38. Tzanakis N, Gazouli M, Rallis G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006 94 : 624 30.
39. Chae YS, Kim JG, Sohn SK, et al. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 2006 71 : 266 72.
40. Gu H, Yang L, Tang N, et al. Association of endothelin-converting enzyme-1b C-338A polymorphism with gastric cancer risk: a case-control study. Eur J Cancer 2008 44 : 1253 8.
41. Wang HD, Ren J, Zhang L. CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol 2004 10 : 3088 93.
42. Li LC, Chui RM, Sasaki M, et al. A single nuclecotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000 60 : 873 6.
43. Wang GY, Lu CQ, Zhang RM, Hu XH, Luo ZW. The E-cadherin gene polymorphism 160C->A and cancer risk: a HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 2008 167 : 7 14.
44. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002 2 : 161 74.
45. Röcken C, Lendeckel U, Dierkes J, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005 11 : 2526 30.
46. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002 2 : 795 803.
47. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000 12 : 1232 5.
48. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002 51 : 1635 9.
49. Suriani R, Colozza M, Cardesi E, et al. CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol 2008 22 : 255 8.
50. West DW, Schuman KL, Lyon JL, Robison LM, Allred R. Differences in risk estimations from a hospital and a population-based case-control study. Int J Epidemiol 1984 13 : 235 9.